First-in-human Study of 10-1074-LS Alone and in Combination With 3BNC117-LS

NCT03554408 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: 10-1074-LS
DRUG: 10-1074-LS
DRUG: 3BNC117-LS
DRUG: 3BNC117-LS

Sponsor

Rockefeller University